Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Clinical trial NCT00903422 · COMPLETED
Trial details
- NCT number
- NCT00903422
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-14
- Primary completion
- 2012-06-26
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.